- Country: Chile
- Summary: Gsp Drug Supply Sunitinib 125Mg 25Mg and 50Mg
- CLT Ref No: 129199643
- Deadline: 10 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CLP 345000000
- Notice Type: Tender
- Document Ref. No.: 1057055-102-LP25
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Products or services: Trastuzumab
The objective of the Proposal is the SUPPLY OF SUNITINIB MEDICINES 12.5MG, 25MG AND 50MG for the San Borja Arriaran Clinical Hospital, requested in the technical specifications, in accordance with the Administrative, Technical Bases, Forms, clarifications and other documents that may be formulated during the course of the tender. It will be understood that every supplier knows and irrevocably accepts the content of these Terms, by the mere fact of submitting offers in this bidding process. bidding. - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINGsp Drug Supply Sunitinib 125Mg 25Mg and 50Mg - Chile Tender
The CENTRAL METROPOLITAN HEALTH SERVICE SAN BORJA ARRIARAN CLINICAL HOSPITAL, a Government sector organization in Chile, has announced a new tender for Gsp Drug Supply Sunitinib 125Mg 25Mg and 50Mg. This tender is published on ChileTenders under CLT Ref No: 129199643 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-10.
The estimated tender value is CLP 345000000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
